CURED BERKELEY
.png)
PILLARS OF CURED
Infectious Diseases & Global Health
Infectious diseases emerge where human and animal life collide, and persist in the communities conventional medicine has left behind. Our researchers are in Africa, Asia, and Latin America asking why mountain gorillas don't get HIV, how bats carry deadly viruses without getting sick, and what those answers mean for human medicine. We are also tackling HIV, tuberculosis, malaria, and drug-resistant infections with the deep laboratory science Berkeley is built to do. Through CURED CORPS, we are training scientists in the regions where these threats emerge, building sustainable local capacity.
Cancer
Cancer kills more than 600,000 Americans every year, and many cancers still cannot be cured with existing treatments. We are going upstream, identifying the fundamental immune pathways and cellular targets that allow cancer to evade, exhaust, and suppress the body's own defenses. A drug that targets one of those shared pathways could work across dozens of cancer types at once. That is the Berkeley way.
Rare Diseases
Rare diseases affect thirty million Americans, most of them genetic, chronic, and severe, and most without an effective treatment. Berkeley is pursuing a paradigm shift: many rare diseases that look unrelated share the same broken biological mechanisms, and the science that cures one could cure hundreds. Thirty million Americans are waiting. Berkeley isn't.
Autoimmune & Inflammatory Diseases
Autoimmune diseases are rising faster than almost any other disease category, disproportionately affect women, and have no cure. We are mapping the genetic pathways that drive autoimmunity, using AI and protein engineering to rewire inflammatory circuits, and developing ways to restore immune tolerance. The goal isn't better management. It's cures.
